Self-reported hepatitis C virus antibody status and risk behavior in young injectors

Public Health Reports

Volumn 121, Issue 6, 2006, Pages 710-719

  Hagan, Holly ^a   Campbell, Jennifer ^b   Thiede, Hanne ^b   Strathdee, Steffanie ^c   Ouellet, Lawrence ^d   Kapadia, Farzana ^e   Hudson, Sharon ^f   Garfein, Richard S ^c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f Health Research Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS ANTIBODY;

ACCURACY; ADOLESCENT; ADULT; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; DRUG USE; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE STATUS; IMMUNOASSAY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; SAFETY; SELF REPORT; SEXUAL BEHAVIOR; UNITED STATES; BLOOD; HEALTH STATUS; ISOLATION AND PURIFICATION; PATHOGENICITY; SELF DISCLOSURE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; FEMALE; HEALTH STATUS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; RISK-TAKING; SELF DISCLOSURE; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 33846457516     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490612100611     Document Type: Article

References (37)

1. Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse 1998;33:1197-212.
2. Hocking J, Crofts N, Aitken C, MacDonald M. Epidemiology of the hepatitis C virus among injecting drug users. In: Crofts N, Dore G, Locarnini S, editors. Hepatitis C: an Australian perspective. Sydney: IP Communications; 2001.
3. Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect 2002;129:577-85.
4. Deuffic-Burban S, Wong JB, Poynard T. Comparing the public health burden of chronic hepatitis C and HIV infection in United States. Presented at the American Association for the Study of the Liver; 2003 Nov 25-29; Boston, MA.
5. Wodak A, Crofts N. Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction 1996;91:181-4.
6. Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis 1996;28:27-9.
7. Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 1997;92:999-1005.
8. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999;149:203-13.
9. Thiede H, Hagan H, Murrill SC. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health 2000;77:331-45.
10. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003;157:467-71.
11. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma Syringe-Exchange Program. Am J Public Health 1995;85:1531-7.
12. Mansson AS, Moestrup T, Nordenfelt E, Widell A. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000;32:253-8.
13. Gordon FD. Cost-effectiveness of screening for hepatitis C. Am J Med 1999;107:36S-40S.
14. Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. "Informed altruism" and "partner restriction" risk reduction among injecting drug users. J Acquir Immune Defic Syndr 2004;35:158-66.
15. Weinhardt LS, Carey MP, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health 1999;89:1397-1405.
16. Kamb ML, Fishbein M, Douglas JM, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998;280:1161-7.
17. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002;97:1289-94.
18. Miller M, Mella I, Moi H, Eskild A. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immun Defic Syndr 2003;33:373-9.
19. Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA.. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis 2002;35:783-8.
20. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42-6.
21. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186:1558-64.
22. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155:645-53.
23. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003;52(RR-3):1-16.
24. Rosenberg M. Society and the adolescent self image. Princeton (NJ): Princeton University Press; 1965
25. Derogatis LR, Milisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595-605.
26. Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004;99:855-9.
27. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1989.
28. Teoh NC, Farrell GC. Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J 2004;34:324-37.
29. Straus SM, Rindskopf DM, Deren S, Falkin GP. Concurrence of drug users' self-report of current HIV status and serotest results. J Acquir Immun Syndr 2001;27:301-7.
30. Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999;319:290-1.
31. Strauss SM, Astone J, Vassilev Z, Des Jarlais DC, Hagan H. Gaps in the drug-free and methadone treatment program response to hepatitis C. J Subst Abuse Treat 2003;24:291-7.
32. Allen SA. Developing a systematic approach to hepatitis C for correctional systems: controversies and emerging consensus. HIV & Hepatitis Education Prison Project-HEPP Report 2003; 6:1-4 [cited 2006 Jun 21]. Available from: URL: http://www.idcronline.org/archives/april03/mainarticle.html
33. Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 2004;99:621-33.
34. Preventive Services Task Force (US). Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med 2004;140:462-4.
35. Management of hepatitis C: 2002 [cited 2006 Jun 26]. NIH Consensus Statement 2002;19:1-46. Available from: URL: http://consensus.nih.gov/2002/ 2002HepatitisC2002116html.htm
36. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998;47(RR19):1-39.
37. Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, DiBeisceglie A. Testing for hepatitis C virus infection should be routine for persons at risk for infection. Ann Intern Med 2004;141:715-7.